State Street CORP Schedule 13G passive stakes
NYSE
State Street Corporation has reported a 4.6% beneficial ownership stake in Arrowhead Pharmaceuticals Inc., holding over 6.3 million common shares.
NYSE
State Street Corporation has disclosed a 4% beneficial ownership stake in Armada Hoffler Properties Inc., primarily through shared voting and dispositive powers.
NYSE
State Street Corporation has disclosed a 6.6% beneficial ownership stake in Alpha Metallurgical Resources Inc., holding 865,934 shares of common stock.
NYSE
State Street Corporation has reported a 6.1% beneficial ownership stake in AES Corp/The, holding over 43.7 million shares as of June 30, 2025.
NYSE
State Street Corporation has reported a 3.8% passive beneficial ownership stake in AeroVironment Inc. common stock.
NYSE
State Street Corporation has reported a 5.1% beneficial ownership stake in ADMA Biologics Inc., signaling significant institutional interest.
NYSE
State Street Corporation has reported a 5.3% beneficial ownership stake in AAR Corp, held for investment purposes.
NYSE
State Street Corporation and its subsidiary SSGA Funds Management, Inc. have reported beneficial ownership of 6.4% and 5.1% respectively in 908 Devices Inc. common stock.
NYSE
State Street Corporation and its affiliate SSGA Funds Management, Inc. have disclosed significant passive ownership stakes in 3D Systems Corp.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting a 13.04% beneficial ownership stake in State Street Corp as of June 30, 2025.
NYSE
State Street Corporation has filed a Schedule 13G, disclosing its beneficial ownership of 4.7% of Zions Bancorp NA's common stock as of March 31, 2025.
NYSE
State Street Corporation has filed a Schedule 13G, revealing a 5.2% beneficial ownership stake in Xencor Inc. as of March 31, 2025.
NYSE
State Street Corporation has filed a Schedule 13G, revealing a 4.9% passive beneficial ownership stake in Wolfspeed Inc.'s common stock as of March 31, 2025.
NYSE
State Street Corporation has filed a Schedule 13G, revealing a 4.5% beneficial ownership stake in Western Alliance Bancorp as of March 31, 2025.
NYSE
State Street Corporation has filed a Schedule 13G, reporting a passive beneficial ownership of 4.6% in Westamerica Bancorp as of March 31, 2025.
NYSE
State Street Corporation has filed a Schedule 13G, revealing a passive beneficial ownership of 6.9% of Warner Bros. Discovery Inc.'s common stock as of March 31, 2025.
NYSE
State Street Corporation has filed a Schedule 13G, reporting a passive beneficial ownership of 4.7% in Veritex Holdings Inc. as of March 31, 2025.
NYSE
State Street Corporation has filed a Schedule 13G, revealing a 5% beneficial ownership stake in Veris Residential Inc. as of March 31, 2025.
NYSE
State Street Corporation, a major financial institution, has disclosed a 6.1% beneficial ownership stake in Ventas Inc., a healthcare real estate investment trust, held for passive investment purposes.
NYSE
State Street Corporation has filed a Schedule 13G, reporting a passive beneficial ownership of 4.4% of Ulta Beauty Inc.'s common stock.
NYSE
State Street Corporation has filed a Schedule 13G, reporting a 4.8% beneficial ownership stake in Triumph Group Inc. as of March 31, 2025, held in the ordinary course of business.
NYSE
State Street Corporation has filed a Schedule 13G, revealing a 4.9% beneficial ownership stake in Tri Pointe Homes Inc. as a passive institutional investor.
NYSE
State Street Corporation has filed a Schedule 13G, reporting a passive beneficial ownership of 4.5% of The Toro Company's common stock as of March 31, 2025.
NYSE
State Street Corporation has reported a passive beneficial ownership of 6.2% in TKO Group Holdings Inc., totaling 5,031,515 shares, as of March 31, 2025.
NYSE
State Street Corporation has reported a 4.7% beneficial ownership stake in TG Therapeutics Inc., held for investment purposes without intent to influence control.
NYSE
State Street Corporation has filed a Schedule 13G, reporting a passive beneficial ownership of 4.8% in Synovus Financial Corp as of March 31, 2025.
NYSE
State Street Corporation has filed a Schedule 13G, reporting a 5.2% beneficial ownership stake in Synaptics Inc. as of March 31, 2025.
NYSE
State Street Corporation has filed a Schedule 13G, revealing a beneficial ownership of 6.4% of SunCoke Energy Inc.'s common stock as of March 31, 2025.
NYSE
State Street Corporation has filed a Schedule 13G, reporting a 4.1% passive beneficial ownership stake in Stepan Co. as of March 31, 2025.
NYSE
State Street Corporation, a major financial services company, has disclosed a 4.7% passive beneficial ownership stake in SouthState Corp's common stock as of March 31, 2025.